PD-L1 testing in advance stage lung cancer using cytology samples: suitability and interobserver agreement. How well are we doing?

被引：0
|
作者：
Elshiekh, M. [1 ]
Iles, S. [1 ]
Hopcroft, D. [1 ]
Trivedi, P. [1 ]
Gupta, N. [1 ]
Bhagwat, P. [1 ]
Viola, P. [1 ]
机构：
[1] Imperial Coll NHS Trust, Cellular Dept, Hammersmith Hosp, London, England
来源：
LUNG CANCER | 2019年 / 127卷
关键词：
D O I：
10.1016/S0169-5002(19)30094-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
50
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 38 条
  • [31] Cost-Effectiveness of PD-L1 Testing in Non-Small Cell Lung Cancer (NSCLC) Using In Vitro Diagnostic (IVD) Versus Laboratory-Developed Test (LDT)
    Hurwitz, Jason T.
    Vaffis, Shannon
    Grizzle, Amy J.
    Nielsen, Soren
    Dodson, Andrew
    Parry, Suzanne
    ONCOLOGY AND THERAPY, 2022, 10 (02) : 391 - 409
  • [32] Cost-Effectiveness of PD-L1 Testing in Non-Small Cell Lung Cancer (NSCLC) Using In Vitro Diagnostic (IVD) Versus Laboratory-Developed Test (LDT)
    Jason T. Hurwitz
    Shannon Vaffis
    Amy J. Grizzle
    Søren Nielsen
    Andrew Dodson
    Suzanne Parry
    Oncology and Therapy, 2022, 10 : 391 - 409
  • [33] A Comparative Study of PD-L1 Protein Expression Using the Ventana SP263 Diagnostic Assay and PD-L1 mRNA Expression Using RNAscope in Formalin Fixed Paraffin Embedded Samples of Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Urothelial Carcinoma (UC)
    Duncan, D.
    Scott, M.
    Scorer, P.
    Walker, J.
    Barker, C.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (03): : S22 - S22
  • [34] Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14
    Konig, D.
    Prince, S. Savic
    Hayoz, S.
    Zens, P.
    Berezowska, S.
    Jochum, W.
    Stauffer, E.
    Braunersreuther, V.
    Trachsel, B.
    Thierstein, S.
    Mark, M.
    Schmid, S.
    Curioni-Fontecedro, A.
    Addeo, A.
    Opitz, I.
    Guckenberger, M.
    Frueh, M.
    Betticher, D. C.
    Ris, H. -b.
    Stupp, R.
    Rothschild, S. I.
    Bubendorf, L.
    Pless, M.
    ESMO OPEN, 2023, 8 (04)
  • [35] Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small cell lung cancer. Retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01 and 16/14.
    Konig, D.
    Prince, S. Savic
    Hayoz, S.
    Zens, P.
    Berezowska, S.
    Jochum, W.
    Stauffer, E.
    Braunersreuther, V.
    Trachsel, B.
    Thierstein, S.
    Mark, M.
    Schmid, S.
    Opitz, I.
    Guckenberger, M.
    Fruh, M.
    Betticher, D. C.
    Ris, H. -B.
    Stupp, R.
    Rothschild, S. I.
    Bubendorf, L.
    Pless, M.
    SWISS MEDICAL WEEKLY, 2022, 152 : 17S - 18S
  • [36] Inter-rater and intra-rater agreement of [99mTc]-labelled NM-01, a single-domain programmed death-ligand 1 (PD-L1) antibody, using quantitative SPECT/CT in non-small cell lung cancer
    Daniel Johnathan Hughes
    Gitasha Chand
    Jessica Johnson
    Damion Bailey
    Kathryn Adamson
    Vicky Goh
    Gary J. R. Cook
    EJNMMI Research, 13
  • [37] Inter-rater and intra-rater agreement of [99mTc]-labelled NM-01, a single-domain programmed death-ligand 1 (PD-L1) antibody, using quantitative SPECT/CT in non-small cell lung cancer
    Hughes, Daniel Johnathan
    Chand, Gitasha
    Johnson, Jessica
    Bailey, Damion
    Adamson, Kathryn
    Goh, Vicky
    Cook, Gary J. R.
    EJNMMI RESEARCH, 2023, 13 (01)
  • [38] Comparison of tumor mutational burden using the Ion Oncomine™ TML and FoundationOne™ assays with routine clinical FFPE tissue samples to predict durable clinical benefit in lung cancer and melanoma patients - a multivariate analysis integrating PD-L1 and CD8+ evaluation
    Heeke, Simon
    Benzaquen, Jonathan
    Long-Mira, Elodie
    Audelan, Benoit
    Lespinet, Virginie
    Bordone, Olivier
    Lalve, Salome
    Zahaf, Katia
    Poudenx, Michel
    Dugourd, Pierre-Michel
    Chassang, Madleen
    Passeron, Thierry
    Delingette, Herve
    Marquette, Charles-Hugo
    Hofman, Veronique
    Ilie, Marius
    Hofman, Paul
    CANCER RESEARCH, 2019, 79 (13)
1234